- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x PYR: PYRUVIC ACID(Non-covalent)
- 2 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
NAI.2: 36 residues within 4Å:- Chain A: I.14, G.15, S.16, G.17, M.18, I.19, G.20, F.38, D.39, V.40, V.41, M.44, Y.71, T.83, A.84, G.85, L.86, T.87, L.102, N.106, I.109, E.112, V.113, I.129, T.130, N.131, L.133, M.154, A.155, L.158, H.186, S.240, A.241, Y.242, P.245
- Ligands: PYR.1
21 PLIP interactions:21 interactions with chain A- Hydrophobic interactions: A:I.19, A:I.129, A:P.245
- Hydrogen bonds: A:G.17, A:M.18, A:I.19, A:V.40, A:G.85, A:L.86, A:L.86, A:N.106, A:E.112, A:N.131, A:N.131, A:M.154, A:H.186
- Water bridges: A:G.20, A:T.87, A:T.87, A:S.240, A:S.240
NAI.6: 35 residues within 4Å:- Chain C: I.14, G.15, S.16, G.17, M.18, I.19, G.20, F.38, D.39, V.40, V.41, M.44, T.83, A.84, G.85, L.86, T.87, L.102, N.106, I.109, E.112, V.113, I.129, T.130, N.131, L.133, M.154, A.155, L.158, H.186, S.240, A.241, Y.242, P.245
- Ligands: PYR.5
19 PLIP interactions:19 interactions with chain C- Hydrophobic interactions: C:I.19, C:I.129, C:P.245
- Hydrogen bonds: C:G.17, C:M.18, C:I.19, C:V.40, C:G.85, C:L.86, C:L.86, C:N.106, C:E.112, C:N.131, C:N.131, C:H.186
- Water bridges: C:G.20, C:T.87, C:S.240, C:S.240
- 2 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.4: 35 residues within 4Å:- Chain B: I.14, G.15, S.16, G.17, M.18, I.19, G.20, F.38, D.39, V.40, V.41, M.44, Y.71, T.83, A.84, G.85, L.86, T.87, L.102, N.106, I.109, E.112, I.129, T.130, N.131, L.133, M.154, A.155, L.158, H.186, S.240, A.241, Y.242, P.245
- Ligands: PYR.3
19 PLIP interactions:19 interactions with chain B- Hydrophobic interactions: B:I.19, B:I.129, B:P.245
- Hydrogen bonds: B:G.17, B:M.18, B:I.19, B:V.40, B:G.85, B:L.86, B:L.86, B:N.106, B:E.112, B:N.131, B:N.131, B:M.154
- Water bridges: B:G.20, B:T.87, B:S.240, B:S.240
NAD.8: 35 residues within 4Å:- Chain D: I.14, G.15, S.16, G.17, M.18, I.19, G.20, F.38, D.39, V.40, V.41, M.44, Y.71, T.83, A.84, G.85, L.86, T.87, L.102, N.106, I.109, E.112, I.129, T.130, N.131, L.133, M.154, A.155, L.158, H.186, S.240, A.241, Y.242, P.245
- Ligands: PYR.7
20 PLIP interactions:20 interactions with chain D- Hydrophobic interactions: D:I.19, D:I.129, D:P.245
- Hydrogen bonds: D:G.17, D:M.18, D:I.19, D:V.40, D:G.85, D:L.86, D:L.86, D:N.106, D:E.112, D:N.131, D:N.131, D:M.154, D:H.186
- Water bridges: D:S.16, D:G.20, D:K.48, D:W.97
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Boucher, J.I. et al., An atomic-resolution view of neofunctionalization in the evolution of apicomplexan lactate dehydrogenases. Elife (2014)
- Release Date
- 2014-07-02
- Peptides
- lactate dehydrogenase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x PYR: PYRUVIC ACID(Non-covalent)
- 2 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Boucher, J.I. et al., An atomic-resolution view of neofunctionalization in the evolution of apicomplexan lactate dehydrogenases. Elife (2014)
- Release Date
- 2014-07-02
- Peptides
- lactate dehydrogenase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D